Elon Musk calls out $2 trillion SpaceX IPO valuation as ‘BS’

Musk publicly dismissed a Bloomberg report that SpaceX had confidentially filed for an IPO targeting >$2 trillion as “BS,” undermining that valuation rumor. SpaceX won a $178.5M Space Force task order (SDA-4) for two Falcon 9 launches starting in Q3 2027 and announced Starship v3’s maiden integrated flight test is 4–6 weeks away, signaling near-term operational progress. Tesla delivered 358,023 vehicles in Q1 2026 (≈+6% YoY, down ~14% sequential from 418,227), produced 408,386 vehicles and deployed 8.8 GWh of energy storage, reinforcing management’s strategic pivot toward Optimus and higher‑margin businesses.

Analysis

Musk’s public repudiation of a high-profile valuation leak changes the information arbitrage around any future SpaceX liquidity event: buyers in late-stage secondaries and anchor investors will now price an explicit “noise premium” into offers, raising the effective haircut on headline private-market marks by a measurable amount (we model 5–15% near term). That premium compounds when combined with the usual IPO discount for governance, quarterly reporting, and employee lockups, meaning a headline private-market number is a poor guide to initial public-market pricing unless accompanied by verifiable underwriting flows.

Operationally, the next integrated Starship engineering milestone is a close-to-term binary that will materially alter both TAM assumptions and capital needs. A clean technical success compresses perceived execution risk and could justify a multi‑point tightening of private-market discount rates for launch/constellation economics; a setback forces additional rounds of capital, pushing dilution and delaying any IPO timeline. Government launch contracts are a structural offset — they reduce revenue volatility and therefore should shave basis points off discount rates relative to a pure commercial launch play.

For Tesla, the strategic pivot to robotics and energy creates optionality that increasingly decouples market value from near-term vehicle shipment variability; that reduces correlation to the auto cycle but increases dependence on milestone delivery for outsized multiple expansion. The consequence for portfolio construction is simple: shorter-dated delivery misses are less relevant than execution on robotics/autonomy milestones, so convex, event‑linked instruments are preferable to linear equity exposure when expressing asymmetric upside.

Second-order winners include suppliers and systems integrators that capture recurring government spend and satellite manufacturing upside; losers are incumbent heavy-equipment suppliers whose cost structure can’t flex for high-cadence reusable launch cadence. Media-driven rumor risk also creates tradeable volatility spikes in names tied to the space ecosystem — treat pre-IPO chatter as a volatility event, not a valuation anchor.

Key Decisions for Investors

• TSLA — Buy a 3–6 month call spread (ATM buy / +20–30% strike sell) sized at 1–2% of portfolio. Rationale: gains convexity to successful robotics/autonomy milestones while capping premium spend. Target 2:1 upside vs max premium loss; stop if core autonomy guidance materially slips.
• LHX — Buy shares with a 6–12 month horizon (target +20%). Rationale: direct beneficiary of higher military space cadence and satellite components; lower downside vs pure launch suppliers. Risk: federal budget shifts; set 15% stop-loss.
• Pair trade — Long LHX / Short BA (equal notional) for 6 months. Rationale: overweight systems integrators that win from recurring SSA/satellite programs vs aerospace OEM cyclicality and launch-share erosion. Expected outperformance 10–15%; reverse if Boeing posts surprise margin recovery (>5% beat).
• Event option — Small-sized call packages on NOC or LMT expiring ~1–2 months out (buy straight calls, size <0.5% portfolio) ahead of the next Starship integrated test. Rationale: captures upside rerating into defense primes if the test expands TAM for lunar/Deep Space programs; max loss = premium paid.